Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)
China flag China · Delayed Price · Currency is CNY
8.86
+0.07 (0.80%)
May 8, 2026, 3:04 PM CST

SHE:300009 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
14,77115,96614,41517,09415,62321,448
Market Cap Growth
12.93%10.76%-15.68%9.42%-27.16%7.00%
Enterprise Value
13,30414,86213,39516,08914,82220,627
Last Close Price
8.869.578.399.678.6411.82
PE Ratio
21.1321.7220.3920.1822.21103.80
Forward PE
18.8514.1614.1617.4721.2735.62
PS Ratio
5.776.035.685.976.709.89
PB Ratio
3.013.373.354.354.597.39
P/TBV Ratio
3.443.903.955.315.438.24
P/FCF Ratio
21.7521.6825.3722.5669.5546.53
P/OCF Ratio
18.2618.5021.0317.9422.3536.22
EV/Sales Ratio
5.205.625.285.616.369.51
EV/EBITDA Ratio
15.2716.2415.3816.2017.7330.48
EV/EBIT Ratio
17.8118.5717.6517.6219.6134.42
EV/FCF Ratio
19.5920.1823.5821.2465.9844.75
Debt / Equity Ratio
0.010.010.010.010.010.01
Debt / EBITDA Ratio
0.030.040.060.060.040.04
Debt / FCF Ratio
0.050.050.100.080.150.06
Net Debt / Equity Ratio
-0.33-0.33-0.32-0.36-0.33-0.38
Net Debt / EBITDA Ratio
-1.89-1.69-1.60-1.41-1.36-1.63
Net Debt / FCF Ratio
-2.40-2.10-2.45-1.85-5.05-2.39
Asset Turnover
0.480.500.500.620.590.61
Inventory Turnover
2.302.402.182.812.622.59
Quick Ratio
3.783.312.952.442.452.74
Current Ratio
4.303.743.412.752.833.07
Return on Equity (ROE)
15.41%16.54%17.39%23.41%23.40%6.98%
Return on Assets (ROA)
8.67%9.37%9.41%12.39%11.92%10.44%
Return on Invested Capital (ROIC)
20.86%23.55%24.86%35.50%32.85%21.45%
Return on Capital Employed (ROCE)
14.70%16.30%17.00%22.20%21.10%19.70%
Earnings Yield
4.70%4.61%4.90%4.96%4.50%0.96%
FCF Yield
4.60%4.61%3.94%4.43%1.44%2.15%
Dividend Yield
2.82%2.61%2.98%2.59%2.89%1.69%
Payout Ratio
37.09%56.24%58.78%48.52%46.59%132.37%
Buyback Yield / Dilution
2.65%0.73%-0.57%-2.34%-2.90%2.58%
Total Shareholder Return
5.48%3.34%2.41%0.25%-0.00%4.28%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.